EP3814374A1 - Complement Alternative Pathway Nephropathy Biomarkers
Summary
Achillion Pharmaceuticals, Inc. has been granted European Patent EP3814374A1 for complement alternative pathway-associated nephropathy biomarkers. The patent, published April 15, 2026, names inventors Huang, Mingjun; Podos, Steven D.; Yang, Wengang; and Zhao, Yongsen, and covers multiple pharmaceutical compositions including C07K peptide classifications. The patent is designated across 31 European states including Germany, France, the United Kingdom, Italy, Spain, and the Netherlands.
About this source
GovPing monitors EPO Patent Bulletin - Peptides (C07K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 46 changes logged to date.
What changed
The EPO has granted European Patent EP3814374A1 to Achillion Pharmaceuticals, Inc. covering complement alternative pathway-associated nephropathy biomarkers and related pharmaceutical compositions. The patent application, which was assigned IPC classifications including C07K 16/18, C07K 16/40, and multiple A61K therapeutic compositions, has proceeded to grant with A1 publication status.
Pharmaceutical and biotechnology companies active in complement pathway research or kidney disease therapeutics should review the patent's claims for potential freedom-to-operate concerns within the designated European contracting states. The granted claims may affect product development programmes targeting complement-mediated nephropathies in markets covered by the designation states including DE, FR, GB, IT, ES, and 26 other European jurisdictions.
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
COMPLEMENT ALTERNATIVE PATHWAY-ASSOCIATED NEPHROPATHY BIOMARKERS
Publication EP3814374A1 Kind: A1 Apr 15, 2026
Applicants
Achillion Pharmaceuticals, Inc.
Inventors
HUANG, Mingjun, PODOS, Steven, D., YANG, Wengang, ZHAO, Yongsen
IPC Classifications
C07K 16/18 20060101AFI20220201BHEP C07K 16/40 20060101ALI20220201BHEP A61K 31/33 20060101ALI20220201BHEP A61K 31/395 20060101ALI20220201BHEP A61K 31/40 20060101ALI20220201BHEP A61K 31/41 20060101ALI20220201BHEP A61K 31/435 20060101ALI20220201BHEP A61K 39/395 20060101ALI20220201BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Parties
Related changes
Get daily alerts for EPO Patent Bulletin - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.